COVID-19 – Information for the animal health sector

Veterinary medicines supply and COVID-19

Veterinary medicines manufacturers always, as a matter of routine, have detailed business continuity plans and are working hard with suppliers to help ensure veterinary medicines remain available to protect the health and welfare of the UK’s animals.

Practices should maintain appropriate inventory levels and follow safety measures in accordance with applicable Government COVID-19 guidance. If this is undertaken, there should be no need for additional stocks.

NOAH works closely with the Veterinary Medicines Directorate (VMD), which has well established mechanisms for dealing with supply issues that arise from time-to-time including robust intelligence-led warning systems to detect potential problems at the earliest point possible. In order to address supply issue concerns, the VMD has enhanced its emergency response plan to support the continued supply of veterinary medicines – whatever the cause.

We would also advise animal owners to heed the advice of the veterinary profession: to discuss the timing of any vaccinations with their vet and urge those whose animals are undergoing long term treatment to seek repeat prescriptions in good time from their veterinary practice.

version 14.05.2020

HealthforAnimals (the global animal health association of which NOAH is a member) has produced a short publication outlining the external contribution of our sector to COVID-19 efforts at a global level: Healthfor Animals: COVID-19_How_We_Are_Acting

See Also